申请人:Purdue Research Foundation
公开号:US10980781B2
公开(公告)日:2021-04-20
The present invention generally relates to 6-amino-2,4-dihydropyrano [2,3-c] pyrazoles as a ubiquitin specific protease 7(USP7) inhibitor useful for the treatment of diseases mediated by malfunction of USP7, such as inflammation, cancer, and immunological disorders. The invention described herein also pertains to pharmaceutical compositions and methods for treating diseases mediated by malfunction of USP7, in mammals using compounds disclosed herein.
本发明一般涉及作为泛素特异性蛋白酶7(USP7)抑制剂的6-氨基-2,4-二氢吡喃并[2,3-c]吡唑,可用于治疗由USP7功能失调介导的疾病,如炎症、癌症和免疫紊乱。本文所述的发明还涉及使用本文公开的化合物治疗哺乳动物中由 USP7 功能失常介导的疾病的药物组合物和方法。